FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)

Q: What does CUSIP 31447P100 represent in this 13F holders report?

CUSIP 31447P100 is the security identifier for FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in Q2 2020?

53 institutional investors reported FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 31447P100

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common stock, no par value (the "Shares")
Shares outstanding: 34,145,841
Total 13F shares: 13,870,610
Share change: +4,536,851
Total reported value: $115,816,682
Put/Call ratio: 170%
Price per share: $8.35
Number of holders: 53
Value change: +$37,949,605
Number of buys: 47
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 31447P100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Southpoint Capital Advisors LP	13F	Company	12%	3,997,214	$23,743,000	—	31 Mar 2020	13F
Avoro Capital Advisors LLC	13F	Company	3.2%	1,105,999	$6,570,000	—	31 Mar 2020	13F
Solas Capital Management, LLC	13F	Company	2.8%	960,000	$5,702,000	—	31 Mar 2020	13F
683 Capital Management, LLC	13F	Company	2.8%	950,000	$5,644,000	—	31 Mar 2020	13F
Sonic Fund II, L.P.	13F	Company	2.4%	834,689	$4,958,000	—	31 Mar 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.1%	720,000	$4,277,000	—	31 Mar 2020	13F
Granahan Investment Management, LLC	13F	Company	0.79%	270,209	$1,605,000	—	31 Mar 2020	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.43%	147,108	$874,000	—	31 Mar 2020	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.38%	129,646	$770,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.26%	88,518	$526,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.22%	76,096	$452,000	—	31 Mar 2020	13F
Hartford Financial Management Inc.	13F	Company	0.12%	42,148	$250,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.1%	33,463	$199,000	—	31 Mar 2020	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.07%	25,439	$151,000	—	31 Mar 2020	13F
WEDBUSH SECURITIES INC	13F	Company	0.07%	24,200	$144,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.06%	19,180	$114,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	14,224	$84,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.03%	9,233	$55,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	8,672	$52,000	—	31 Mar 2020	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0.01%	1,840	$11,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	1,800	$11,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0%	1,118	$7,000	—	31 Mar 2020	13F
Wealth Quarterback LLC	13F	Company	0%	1,000	$5,940	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0%	371	$2,000	—	31 Mar 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	62	$368	—	31 Mar 2020	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	1	$14	—	31 Mar 2020	13F

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q2 2020

As of 30 Jun 2020, FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,870,610 shares. The largest 10 holders included Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, Sonic Fund II, L.P., EVENTIDE ASSET MANAGEMENT, LLC, 683 Capital Management, LLC, BlackRock Inc., Solas Capital Management, LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and NORTHERN TRUST CORP. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.